Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Probable late second dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: Probable late second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 01-AUG-2024 and 02-AUG-2024 A voicemail was left by a healthcare professional with the following message, a probable late second dose. The patient was not sure if they had a dose of Shingrix administered or not when they consulted their healthcare professional. No further details provided by reporter. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine which led to incomplete course of vaccination.